Rayner announces launch of RayOne Galaxy spiral IOL

News
Article

The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain

The RayOne Galaxy spiral IOL in a package. Image courtesy of Rayner.

Clinical investigators are expected to present their findings on the RayOne Galaxy at this year's ESCRS meeting in Barcelona, Spain. Image courtesy of Rayner.

On Monday, ophthalmic surgery manufacturer Rayner announced a new addition to its intraocular lens (IOL) offering, designed using a proprietary artificial intelligence (AI) engine. In a press release, Rayner, based in Worthing, UK, shared details about the RayOne Galaxy and Galaxy Toric, which will launch at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) Congress in Barcelona, Spain.1 The lens will come fully preloaded across the RayOne product line’s power range and will be immediately available in toric powers.

According to Rayner, the RayOne Galaxy has a unique spiral lens, formulated to deliver a continuous full range of vision and minimise dysphotopsia. The company developed the RayOne Galaxy in conjunction with João Marcelo Lyra, MD, PHD, who is affiliated with Universidade Estadual de Ciências da Saúde de Alagoas (UNCISAL), Maceio, Alagoas, Brazil. Additionally, the IOL was developed using an AI “trained on patient outcomes,” resulting in a non-diffractive optic with 0% light loss. The press release from Rayner noted the lens is the “world’s first spiral IOL designed with artificial intelligence.”

Clinical investigations with RayOne Galaxy began earlier in 2024 in Brazil and throughout Europe.1 Eight leading surgeons began using the RayOne Galaxy in their clinical practices, and a number of those surgeons will present initial findings at a Rayner symposium during the ESCRS Congress. Mr Allon Barsam, Consultant Ophthalmic Surgeon and Director at OCL Vision in London, United Kingdom, said the first patients received the RayOne Galaxy lens at OCL Vision in July. “Their feedback so far has been overwhelmingly positive, with patients reading without glasses and thrilled with their quality of vision,” Mr Barsam reported in the press release.

Tim Clover, CEO of Rayner, gave a statement about the AI-supported development of the lens. “We all read about the life changing potential of AI, but this is a real-world example of technology impacting the outcomes of patients,” he said. “RayOne Galaxy represents a next generation technology in intraocular lenses to enable patients to see without spectacles.”

Reference

1. Rayner announces launch of world’s first spiral IOL designed with AI. Press release. Rayner Group. Published 26 August, 2024.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.